Is there a role for consolidation therapy pre-transplantation?

Best Practice & Research. Clinical Haematology
J M Rowe

Abstract

There is much confusion and uncertainty regarding the need for consolidation therapy before bone marrow transplantation. There are no prospective studies that have established clear guidelines and much of the information has been based on retrospective analyses of data obtained from the international bone marrow transplant registries. These data suggest that there may not be a role for consolidation therapy before an allogeneic transplantation. However, this may not be applicable to transplants performed following reduced intensity conditioning or to transplants performed beyond first remission. The data for autologous transplantation are substantially more confused. Common practice includes the administration of consolidation therapy prior to transplantation, although there is enormous variability in the amount of cycles and in the doses that are given before transplantation.

Citations

May 20, 2009·Future Oncology·Cortney V Jones, Edward A Copelan
Dec 1, 2011·Psychological Science in the Public Interest : a Journal of the American Psychological Society·Jennifer L SkeemScott O Lilienfeld

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Best Practice & Research. Clinical Haematology
Frederick R Appelbaum, S Frieda Pearce
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Martin S TallmanMary M Horowitz
Blood
Frederick R AppelbaumStephen H Petersdorf
Best Practice & Research. Clinical Haematology
Martin S Tallman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Lionel AdèsEuropean Acute Promyelocytic Leukemia Group
© 2021 Meta ULC. All rights reserved